Systems biology approaches for advancing the discovery of effective drug combinations

Area of Science:

• Oncology
• Systems Biology
• Bioinformatics

Background:

• Cancer complexity involves interconnected networks regulating cell proliferation, invasion, and drug resistance.
• Current cancer therapy often uses a reductionist one gene-one disease approach, which can lead to drug resistance.
• Identifying optimal drug combinations is challenging due to the vast number of possibilities.

Purpose of the Study:

• To review computational modeling, bioinformatics, and high-throughput experimental methods for discovering cancer drug combinations.
• To highlight systems biology approaches for prioritizing drug combination experiments and reducing the search space.
• To provide a list of resources for facilitating drug combination discovery.

Main Methods:

• Large-scale modeling of cell signaling networks
• Network motif analysis and statistical association-based models
• Functional genomics and high-throughput combination screening

Main Results:

• Systems approaches offer strategies to overcome drug resistance by limiting mutations and escape pathways.
• Integration of diverse systems biology methods enables faster discovery of drug combinations.
• Publicly available data and resources can aid in the discovery process.

Conclusions:

• Systems biology approaches are essential for advancing cancer therapy beyond reductionist models.
• Combining computational and experimental methods accelerates the identification of effective drug combinations.
• Faster discovery and translation of clinically relevant drug combinations are achievable through integrated systems approaches.